Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Cosmetic and Laser Updates: GLP-1 Facial Changes, Biostimulatory Fillers, Microcoring, and Emerging Treatments

Description

Dr. Sandy Tsao reviewed recent cosmetic and laser advances, beginning with GLP-1–associated facial volume loss and skin laxity seen after major weight loss. She emphasized that early intervention with hyaluronic acid fillers plus biostimulatory agents such as poly-L-lactic acid or calcium hydroxylapatite can help preserve contour, improve skin quality, and support regenerative collagen formation. She then discussed poly-L-lactic acid as a long-used biostimulator now applied beyond the face to the neck, chest, buttocks, arms, knees, and abdomen in hyperdilute form, with results lasting years. A newer dermal microcoring device was presented as a minimally invasive option for moderate-to-severe wrinkles and some skin tightening, though technique matters and scarring can still occur. The talk also highlighted expanding uses of botulinum toxin: a liposomal cream for hyperhidrosis, toxin injections for Raynaud’s phenomenon and Hailey-Hailey disease, hyaluronidase for microstomia in systemic sclerosis, and botulinum toxin E as a fast-on, short-duration neurotoxin useful for event-based or first-time patients. Finally, she described microdroplet botulinum toxin for facial slimming, seborrhea, rosacea, and enlarged pores, and ultrasound-based therapy for skin tightening and acne scar improvement, stressing that many newer approaches aim to combine efficacy, safety, and regenerative outcomes.

View more

Conclusions

  • GLP-1–associated weight loss can produce noticeable facial volume loss and skin laxity, so early intervention with fillers and biostimulatory agents may help patients maintain a more natural appearance while continuing treatment.
  • Combined hyaluronic acid and poly-L-lactic acid regimens appear to improve facial contour, skin thickness, hydration, radiance, and patient satisfaction in people using GLP-1 medications.
  • Poly-L-lactic acid is emerging as a regenerative biostimulator not only for the face but also for off-face body areas such as the neck, chest, buttocks, arms, knees, and abdomen, with benefits that may last for years.
  • Dermal microcoring can meaningfully reduce moderate facial wrinkles and some body laxity, but its benefits are technique-dependent and it may still cause visible grid-pattern scarring, so it is not entirely scarless.
  • Botulinum toxin has expanded beyond wrinkle treatment and can be useful for hyperhidrosis, Raynaud phenomenon, Hailey-Hailey disease, seborrhea, rosacea, and enlarged pores.
  • Topical liposomal botulinum toxin may offer a less invasive alternative for axillary hyperhidrosis, but injectables still provide a more established effect.
  • Botulinum toxin A can improve Raynaud symptoms, finger warmth, ulcer healing, and swelling, suggesting a real vascular and symptomatic benefit in selected patients.
  • Perilesional botulinum toxin A can reduce pain and lesions in Hailey-Hailey disease, and lasers may provide longer remissions in more severe cases.
  • Perioral hyaluronidase injections can improve microstomia in systemic sclerosis, increasing oral aperture and function in a way that patients may find life-changing.
  • Botulinum toxin E introduces a new cosmetic neurotoxin option with very rapid onset and very short duration, making it especially attractive for first-time or event-based users who want temporary results.
  • Microdroplet botulinum toxin techniques may provide modest lifting effects and can improve seborrhea, acne, rosacea redness, and facial pore size when placed superficially and carefully.
  • Microcoring may also be useful for enlarged pores, offering a more durable but procedure-based alternative to microbotox.
  • Ultrasound-based skin tightening is a safe non-surgical option for mild to moderate laxity because it targets deeper tissues while sparing the epidermis and working across skin types.
  • High-intensity parallel ultrasound shows promise for acne atrophic scars by stimulating collagen remodeling with minimal downtime, broad skin-type applicability, and strong early safety and improvement signals.
  • Aesthetic Surgery Journal 2025, Vol 00(0) 1–11.
  • Aesthetic Plastic Surgery, 2024. DOI mentioned.
  • Plastic and Reconstructive Surgery Global Open, published online October 2022.#10.1097/gox.0b013e31828e2fc7
  • DERMATOLOGIC SURGERY 2024.
  • Australasian Journal of Dermatology (2018), Charlton, Stewart, and Rosen.
  • Journal of the American Academy of Dermatology retrospective cohort study.
  • Toxins 2021, 13, 817.
  • The Journal of Clinical and Aesthetic Dermatology, article on botulinum toxin for flushing and persistent erythema in rosacea.
  • Facial Plastic Surgery Clinics of North America, 2023.
  • Dermatologic Surgery • August 2025 • Volume 51 • Number 8.